Related Experiment Videos
[Neurohormonal factors in heart failure. I]
J Cosín Aguilar1, J M Cruz Fernández, E de Teresa Galván
1Hospital Le Fe, Valencia.
Revista Espanola De Cardiologia
|April 1, 1996
Summary
Heart failure involves complex neurohormonal systems that initially compensate but can worsen the condition. Inhibiting these systems, like the aldosterone renin-angiotensin system, is crucial for managing heart failure progression and improving outcomes.
Area of Science:
- Cardiology
- Physiopathology
- Pharmacology
Background:
- Heart failure is a growing health concern characterized by compensatory mechanisms.
- Neurohormonal systems, including sympathetic and aldosterone renin-angiotensin systems, play a key role in heart failure.
- These systems involve both vasoconstrictor and vasodilator pathways that modulate cardiovascular response.
Purpose of the Study:
- To review the physiopathology of neurohormonal systems in heart failure.
- To analyze the diagnostic and prognostic significance of these systems.
- To evaluate the impact of neurohormonal activation on heart failure progression.
Main Methods:
- Review of literature on neurohormonal systems in heart failure.
- Analysis of the deleterious effects of neurohormonal activation.
- Examination of current pharmacological treatments and their effects on neurohormonal pathways.
Main Results:
- Neurohormonal activation can have detrimental effects, contributing to a vicious cycle in heart failure.
- Inhibition of the aldosterone renin-angiotensin system is vital for heart failure prophylaxis and treatment.
- Inhibition of the sympathetic nervous system shows value in specific heart failure types.
Conclusions:
- Understanding neurohormonal pathways is essential for diagnosing and managing heart failure.
- Targeting neurohormonal systems offers significant therapeutic benefits.
- Pharmacological interventions must consider their impact on neurohormonal balance for optimal heart failure management.